Attentive Science
Attentive Science is a privately held, boutique nonclinical CRO providing GLP and non-GLP pharmacokinetics, toxicology, and safety pharmacology services to biotech, pharmaceutical, animal health, and agrochemical clients across facilities in the USA, Australia, and Abu Dhabi.
- Company typePrivate
- Founded2019
- HeadquartersStilwell, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Attentive Science does
Attentive Science is a privately held, founder-led nonclinical contract research organization (CRO) specializing in pharmacokinetics, toxicology, and safety pharmacology studies that support IND-enabling drug development programs. The company serves biotechnology, pharmaceutical, animal health, and agrochemical clients, conducting both GLP and non-GLP studies and providing SEND-compliant data conversion for FDA, TGA, and EMA submissions. Its service portfolio includes core in-vivo PK and toxicology offerings alongside specialized capabilities such as C-arm and X-ray fluoroscopic imaging for gene therapy and medical device studies, immunohistochemistry and immunofluorescence histology, and AAV biodistribution studies aligned with ICH S12 guidelines.
The company operates regional facilities in Stilwell, Kansas (USA), Melbourne (Australia), and Masdar City, Abu Dhabi (UAE), where it has established a 50,000+ square foot facility designated as a national hub for Life Sciences by the Abu Dhabi Department of Health. Attentive Science's go-to-market is a consultative, sales-led boutique CRO model that emphasizes direct client access to scientists and study directors, rapid study initiation, and competitive pricing targeted at emerging biotech companies. Revenue is generated through project-based, fee-for-service contracts priced on study complexity, test systems, and regulatory requirements, with multi-year engagement cycles.
The company's competitive position is anchored by a team of industry veterans (20+ decades combined experience) drawn from former Xenometrics, Sanofi, Pfizer, WIL Research, Quintiles, and Citoxlab backgrounds, and by regulatory credibility evidenced by AAALAC International accreditation, GLP and 21 CFR Part 11 compliance, SENDIG V3.0/V3.1 conformance, and a 2024 FDA surveillance inspection that resulted in zero study-related issues.
Attentive Science firmographics
Firmographics- Name
- Attentive Science
- Legal name
- Attentive Science, LLC
- Website
- https://attentivescience.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Attentive Science is a privately held, boutique nonclinical CRO providing GLP and non-GLP pharmacokinetics, toxicology, and safety pharmacology services to biotech, pharmaceutical, animal health, and agrochemical clients across facilities in the USA, Australia, and Abu Dhabi.
- Ownership category
- akta.pro rank
Attentive Science industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)
- akta.pro secondary industries
- Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)
Keywords
Where Attentive Science is headquartered
LocationHeadquarters
- HQ city
- Stilwell
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Attentive Science business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Contract Research Services: Attentive Science operates as a fee-for-service CRO providing nonclinical research services to biotech, pharmaceutical, animal health, agrochemical, and food industry clients. Services include pharmacokinetics, toxicology, and safety pharmacology studies conducted under GLP and non-GLP conditions. Revenue is generated through project-based contracts for study execution, with pricing based on study complexity, test systems, and regulatory requirements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing based on study requirements |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Attentive Science product offering
Product offeringCore offering
Attentive Science is a boutique nonclinical contract research organization (CRO) that conducts pharmacokinetics, toxicology, and safety pharmacology studies for drug development. The company executes both GLP and non-GLP studies in support of IND-enabling programs and regulatory submissions, offering specialized capabilities including C-arm/X-ray imaging for gene therapy, IHC/IF histology, AAV biodistribution studies, and SEND data conversion.
Product overview
Attentive Science is a global nonclinical contract research organization (CRO) offering a unified platform of preclinical drug development services organized around three core pillars: Pharmacokinetics Studies, Toxicology Studies (including Acute, Subchronic, and IND-enabling programs), and Safety Pharmacology Studies. These core services are supported by specialized capabilities including C-arm and X-ray imaging for gene therapy and device studies, in-house histology with IHC and IF staining, AAV biodistribution studies following ICH S12 guidelines, and SEND data conversion services using Instem's submitTM. The company operates regional facilities in Stilwell, KS (USA), Melbourne, Australia, and Masdar City, Abu Dhabi (UAE), and participates in the Biosphere Labs shared laboratory partnership in Abu Dhabi. Services span both GLP-compliant and non-GLP exploratory studies across biotechnology, pharmaceutical, animal health, and agrochemical industries.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmacokinetics Studies In vivo pharmacokinetic studies evaluating compound behavior within complete physiological systems, measuring systemic exposure, absorption, bioavailability, tissue distribution, metabolic pathways, and clearance rates to support candidate selection and IND-enabling programs. Targets biotech and pharmaceutical companies.
- Toxicology Studies Regulatory toxicology studies evaluating relationships between drug molecule doses and adverse events, including acute, subchronic, chronic, and dose range-finding studies supporting lead optimization, candidate selection, and IND-enabling submissions. Targets biotech and pharmaceutical companies.
- Safety Pharmacology Studies Safety pharmacology studies designed to detect undesirable pharmacodynamic effects of new chemical entities on physiological functions in relation to therapeutic-range and above exposure levels, leveraging a broad expert network. Targets biotech and pharmaceutical companies.
- C-arm and X-ray Imaging Services Real-time fluoroscopic C-arm and X-ray imaging for preclinical gene therapy and medical device studies, enabling non-invasive visualization of catheter and injection needle navigation, gene expression monitoring, vector integrity assessment, and device placement tracking. Targets gene therapy and medical device developers.
- Histology Services (IHC and IF Staining) In-house histology laboratory services including immunohistochemistry (IHC) and immunofluorescence (IF) staining, enabling molecular analysis of tissue samples with specialized markers such as CD80, CD163 EDHu antibody, and DAPI nuclear counterstaining for macrophage polarization and pathological change identification. Targets preclinical and toxicology research programs.
- SEND Data Conversion Services
Companies that use Attentive Science
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Attentive Science technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
Attentive Science partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- M42coreM42 is a health company collaborating with Attentive Science and Masdar City on Biosphere Labs, the GCC's first commercially scaled shared laboratory facility. This partnership provides researchers, startups, and biotechnology companies with access to specialized bench space, advanced equipment, and connections to Abu Dhabi's broader life sciences ecosystem through the HELM cluster. The initiative aims to position Abu Dhabi as a global destination for life sciences innovation.
- Masdar CitycoreMasdar City in Abu Dhabi hosts the Biosphere Labs facility developed in partnership with M42 and Attentive Science. Masdar City is designated by Abu Dhabi Department of Health as the national hub for Life Sciences. Attentive Science operates facilities within Masdar City as part of this strategic partnership.
- Abu Dhabi Department of Health (DOH)flagshipAbu Dhabi Department of Health designated Masdar City as the national hub for Life Sciences and provided active support in attracting Attentive Science's expansion to Abu Dhabi. The DOH's collaborative spirit presented a unique opportunity for Attentive Science's global expansion.
Scale indicators4 records
Recent moves2 records
Expansion highlights6 records
Attentive Science competitors and assessment
Company assessmentBroad incumbents
- Charles River Laboratories: Global CRO giant with end-to-end preclinical and clinical offerings, including the safety assessment and toxicology franchise Attentive Science competes in. Charles River acquired WIL Research and Citoxlab — both prior employers of Attentive's COO — making it the dominant incumbent in the boutique's target niche.
- Labcorp (Covance Drug Development): One of the largest preclinical-to-clinical CROs, with full-service safety pharmacology, toxicology, and bioanalytical labs. Competes with Attentive Science for IND-enabling programs from biotech and pharma sponsors.
- WuXi AppTec: Chinese-headquartered global CRO offering preclinical toxicology, safety pharmacology, and bioanalysis alongside broader drug-development services. Overlaps directly with Attentive Science's toxicology and PK offerings and competes for multinational biotech sponsors.
Direct peers
- Inotiv: Mid-sized US preclinical CRO providing toxicology, safety pharmacology, and PK services to pharma and biotech. Closely comparable in size, services, and target customer base to Attentive Science.
- Pharmaron: Global CRO with integrated preclinical toxicology, safety pharmacology, DMPK, and bioanalytical services. Direct competitor for nonclinical CRO contracts from biotech and pharma sponsors worldwide.
- Frontage Laboratories: US-listed CRO offering preclinical toxicology, pharmacokinetics, and bioanalytical services across US and China operations. Comparable in service mix and customer segments to Attentive Science.
- ITR Laboratories Canada: Boutique preclinical CRO specializing in general toxicology, safety pharmacology, and bioanalysis for pharma and biotech. Closely matches Attentive Science's boutique service profile.
- Smithers: CRO offering preclinical toxicology, safety assessment, and regulatory science services for pharmaceutical, animal health, and agrochemical clients — overlapping Attentive Science's four target verticals.
- Absorption Systems: Specialty preclinical CRO with deep expertise in ADME/PK and drug-drug interaction studies. Comparable in scale and service specialization to Attentive Science's high-throughput in-vivo PK business.
- Seventh Wave Laboratories: Boutique preclinical CRO providing in-vivo toxicology, pharmacokinetics, and safety pharmacology services to emerging biotech. Most closely mirrors Attentive Science's boutique CRO positioning and target customer profile.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Attentive Science social profiles
Digital presenceAttentive Science compliance and trust
Trust signalCompliance4 records
Attentive Science financial estimates
Financial estimateRevenue estimate
Valuation estimate
Attentive Science leadership team
Management profileNumber of profiles
Profiles7 records
Attentive Science subsidiaries and ownership
Company hierarchySubsidiaries2 records
Attentive Science funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Attentive Science M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Attentive Science
What does Attentive Science do?
Attentive Science is a boutique nonclinical contract research organization (CRO) that conducts pharmacokinetics, toxicology, and safety pharmacology studies for drug development. The company executes both GLP and non-GLP studies in support of IND-enabling programs and regulatory submissions, offering specialized capabilities including C-arm/X-ray imaging for gene therapy, IHC/IF histology, AAV biodistribution studies, and SEND data conversion.
Is Attentive Science a public or private company?
Attentive Science is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Attentive Science founded?
Attentive Science was founded in 2019. It employs 11 to 50 people.
Where is Attentive Science based?
Attentive Science is headquartered in Stilwell, United States, in the North America region.
How does Attentive Science make money?
One revenue line is on record: contract Research Services.
Who are Attentive Science's main competitors?
Broad incumbents on record are Charles River Laboratories, Labcorp (Covance Drug Development) and WuXi AppTec. Direct peers are Inotiv, Pharmaron, Frontage Laboratories, ITR Laboratories Canada, Smithers, Absorption Systems and Seventh Wave Laboratories.
Does Attentive Science have an API?
No public API is recorded for Attentive Science.
What industry is Attentive Science in?
Attentive Science's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP), with a secondary code of HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK). Its NAICS code is 54171 and its SIC code is 8731.